Fast and efficient multitransgenic modification of human pluripotent stem cells

Human Gene Therapy Methods

Volumn 25, Issue 2, 2014, Pages 136-153

  Schwanke, Kristin ^a   Merkert, Sylvia ^a   Kempf, Henning ^a   Hartung, Susann ^a   Jara Avaca, Monica ^a   Templin, Christian ^a,b   Göhring, Gudrun ^a   Haverich, Axel ^a   Martin, Ulrich ^a   Zweigerdt, Robert ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; BETA TUBULIN; PLASMID VECTOR; SODIUM IODIDE SYMPORTER; TRANSCRIPTION FACTOR SOX17; TROPONIN T; COTRANSPORTER; RADIOACTIVE IODINE; VENTRICULAR MYOSIN;

ANIMAL CELL; ANIMAL TISSUE; ANTIBIOTIC RESISTANCE; ARTICLE; CELL CLONE; CELL DIFFERENTIATION; CELL LINEAGE; CELL SURVIVAL; CELL TRACKING; CELL VIABILITY; DNA MODIFICATION; ELECTROPORATION; EMBRYO; EXPRESSION VECTOR; GENETIC MANIPULATION; HEART MUSCLE CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSIENT TRANSFECTION; ANIMAL; ANIMAL MODEL; CELL LINE; CHEMISTRY; CYTOLOGY; DIAGNOSTIC USE; DRUG RESISTANCE; GENE VECTOR; GENETICS; HEART; METABOLISM; PLASMID; RAT; SCINTISCANNING; SWINE; TRANSGENE;

ANIMALS; CELL DIFFERENTIATION; CELL LINE; DRUG RESISTANCE; GENETIC VECTORS; HEART; HUMANS; IODINE RADIOISOTOPES; MICE; MODELS, ANIMAL; MYOCYTES, CARDIAC; PLASMIDS; PLURIPOTENT STEM CELLS; RATS; SWINE; SYMPORTERS; TRANSGENES; VENTRICULAR MYOSINS;

EID: 84898767673     PISSN: 19466536     EISSN: 19466544     Source Type: Journal    
DOI: 10.1089/hgtb.2012.248     Document Type: Article

References (66)

1. Ackermann, M., Lachmann, N., Hartung, S., et al. (2014). Promoter and lineage independent anti-silencing activity of the A2 ubiquitous chromatin opening element for optimized human pluripotent stem cell-based gene therapy. Biomaterials 35, 1531-1542
2. Acton, P.D., and Kung, H.F. (2003). Small animal imaging with high resolution single photon emission tomography. Nucl. Med. Biol. 30, 889-895
3. Alexopoulou, A.N., Couchman, J.R., and Whiteford, J.R. (2008). The CMV early enhancer/chicken b actin (CAG) promoter can be used to drive transgene expression during the differentiation of murine embryonic stem cells into vascular progenitors. BMC Cell Biol. 9, 2
4. Amit, M., and Itskovitz-Eldor, J. (2002). Derivation and spontaneous differentiation of human embryonic stem cells. J. Anat. 200, 252-232
5. Argyros, O., Wong, S.P., and Harbottle, R.P. (2011). Non-viral episomal modification of cells using S/MAR elements. Expert Opin. Biol. Ther. 11, 1177-1191
6. Boecker, W., Bernecker, O.Y., Wu, J.C., et al. (2004). Cardiacspecific gene expression facilitated by an enhanced myosin light chain promoter. Mol. Imaging 3, 69-75
7. Braam, S.R., Denning, C., Matsa, E., et al. (2008a). Feeder-free culture of human embryonic stem cells in conditioned medium for efficient genetic modification. Nat. Protoc. 3, 1435-1443
8. Braam, S.R., Denning, C., Van Den Brink, S., et al. (2008b). Improved genetic manipulation of human embryonic stem cells. Nat. Methods 5, 389-392
9. Braam, S.R., Denning, C., and Mummery, C.L. (2010). Genetic manipulation of human embryonic stem cells in serum and feeder-free media. Methods Mol. Biol. 584, 413-423
10. Burridge, P.W., Thompson, S., Millrod, M.A., et al. (2011). A universal system for highly efficient cardiac differentiation of human induced pluripotent stem cells that eliminates interline variability. PLoS One 6, e18293
11. Cahan, P., and Daley, G.Q. (2013). Origins and implications of pluripotent stem cell variability and heterogeneity. Nat. Rev. Mol. Cell. Biol. 14, 357-368
12. Cao, F., Xie, X., Gollan, T., et al. (2010). Comparison of genetransfer efficiency in human embryonic stem cells. Mol. Imaging Biol. 12, 15-24
13. Catalina, P., Montes, R., Ligero, G., et al. (2008). Human ESCs predisposition to karyotypic instability: Is a matter of culture adaptation or differential vulnerability among hESC lines due to inherent properties? Mol. Cancer 7, 76
14. Chang, G.Y., Xie, X., and Wu, J.C. (2006). Overview of stem cells and imaging modalities for cardiovascular diseases. J. Nucl. Cardiol. 13, 554-569
15. Chen, C.M., Krohn, J., Bhattacharya, S., and Davies, B. (2011). A comparison of exogenous promoter activity at the ROSA26 locus using a PhiC31 integrase mediated cassette exchange approach in mouse ES cells. PLoS One 6, e23376
16. Chen, R., John, J., Lavrentieva, A., et al. (2012). Cytokine production using membrane adsorbers: Human basic fibroblast growth factor produced by Escherichia coli. Eng. Life Sci. 12, 29-38
17. Cherry, S.R., Biniszkiewicz, D., Van Parijs, L., et al. (2000). Retroviral expression in embryonic stem cells and hematopoietic stem cells. Mol. Cell. Biol. 20, 7419-7426
18. Costa, M., Dottori, M., Ng, E., et al. (2005). The hESC line Envy expresses high levels of GFP in all differentiated progeny. Nat. Methods 2, 259-260
19. Costa, M., Dottori, M., Sourris, K., et al. (2007). A method for genetic modification of human embryonic stem cells using electroporation. Nat. Protoc. 2, 792-796
20. Dai, W., Field, L.J., Rubart, M., et al. (2007). Survival and maturation of human embryonic stem cell-derived cardiomyocytes in rat hearts. J. Mol. Cell. Cardiol. 43, 504-516
21. David, R., Stieber, J., Fischer, E., et al. (2009). Forward programming of pluripotent stem cells towards distinct cardiovascular cell types. Cardiovasc. Res. 84, 263-272
22. Ellis, J., and Yao, S. (2005). Retrovirus silencing and vector design: Relevance to normal and cancer stem cells? Curr. Gene Ther. 5, 367-373
23. Enver, T., Soneji, S., Joshi, C., et al. (2005). Cellular differentiation hierarchies in normal and culture-Adapted human embryonic stem cells. Hum. Mol. Genet. 14, 3129-3140
24. Graichen, R., Xu, X., Braam, S.R., et al. (2008). Enhanced cardiomyogenesis of human embryonic stem cells by a small molecular inhibitor of p38 MAPK. Differentiation 76, 357-370
25. Haas, D.L., Case, S.S., Crooks, G.M., and Kohn, D.B. (2000). Critical factors influencing stable transduction of human CD34+ cells with HIV-1-derived lentiviral vectors. Mol. Ther. 2, 71-80
26. Haase, A., Olmer, R., Schwanke, K., et al. (2009). Generation of induced pluripotent stem cells from human cord blood. Cell Stem Cell 5, 434-441
27. Hartung, S., Schwanke, K., Haase, A., et al. (2013). Directing cardiomyogenic differentiation of human pluripotent stem cells by plasmid-based transient overexpression of cardiac transcription factors. Stem Cells Dev. 22, 1112-1125
28. Hong, S., Hwang, D.Y., Yoon, S., et al. (2007). Functional analysis of various promoters in lentiviral vectors at different stages of in vitro differentiation of mouse embryonic stem cells. Mol. Ther. 15, 1630-1639
29. Huber, I., Itzhaki, I., Caspi, O., et al. (2007). Identification and selection of cardiomyocytes during human embryonic stem cell differentiation. FASEB J. 21, 2551-2563
30. Jang, J.E., Shaw, K., Yu, X.J., et al. (2006). Specific and stable gene transfer to human embryonic stem cells using pseudotyped lentiviral vectors. Stem Cells Dev. 15, 109-117
31. Kita-Matsuo, H., Barcova, M., Prigozhina, N., et al. (2009). Lentiviral vectors and protocols for creation of stable hESC lines for fluorescent tracking and drug resistance selection of cardiomyocytes. PLoS One 4, e5046
32. Klug, M.G., Soonpaa, M.H., Koh, G.Y., and Field, L.J. (1996). Genetically selected cardiomyocytes from differentiating embryonic stem cells form stable intracardiac grafts. J. Clin. Invest. 98, 216-224
33. Knop, M., Barr, F., Riedel, C.G., et al. (2002). Improved version of the red fluorescent protein (drFP583/DsRed/RFP). Biotechniques 33, 592, 594, 596-598 passim
34. Kustikova, O., Fehse, B., Modlich, U., et al. (2005). Clonal dominance of hematopoietic stem cells triggered by retroviral gene marking. Science 308, 1171-1174
35. Liew, C.G., Draper, J.S., Walsh, J., et al. (2007). Transient and stable transgene expression in human embryonic stem cells. Stem Cells 25, 1521-1528
36. Liu, J., Jones, K.L., Sumer, H., and Verma, P.J. (2009). Stable transgene expression in human embryonic stem cells after simple chemical transfection. Mol. Reprod. Dev. 76, 580-586
37. Livak, K.J., and Schmittgen, T.D. (2001). Analysis of relative gene expression data using real-Time quantitative PCR and the 2-DDCt method. Methods 25, 402-408
38. Ma, Y., Ramezani, A., Lewis, R., et al. (2003). High-level sustained transgene expression in human embryonic stem cells using lentiviral vectors. Stem Cells 21, 111-117
39. Mandegar, M.A., Moralli, D., Khoja, S., et al. (2011). Functional human artificial chromosomes are generated and stably maintained in human embryonic stem cells. Hum. Mol. Genet. 20, 2905-2913
40. Mauritz, C., Martens, A., Rojas, S.V., et al. (2011). Induced pluripotent stem cell (iPSC)-derived Flk-1 progenitor cells engraft, differentiate, and improve heart function in a mouse model of acute myocardial infarction. Eur. Heart J. 32, 2634-2641
41. Moore, J.C., Van Laake, L.W., Braam, S.R., et al. (2005). Human embryonic stem cells: Genetic manipulation on the way to cardiac cell therapies. Reprod. Toxicol. 20, 377-391
42. Moore, J.C., Atze, K., Yeung, P.L., et al. (2010). Efficient, high-Throughput transfection of human embryonic stem cells. Stem Cell Res. Ther. 1, 23
43. Norrman, K., Fischer, Y., Bonnamy, B., et al. (2010). Quantitative comparison of constitutive promoters in human ES cells. PLoS One 5, e12413
44. Okita, C., Sato, M., and Schroeder, T. (2004). Generation of optimized yellow and red fluorescent proteins with distinct subcellular localization. Biotechniques 36, 418-22, 424
45. Olmer, R., Haase, A., Merkert, S., et al. (2010). Long term expansion of undifferentiated human iPS and ES cells in suspension culture using a defined medium. Stem Cell Res. 5, 51-64
46. Palecek, J., Zweigerdt, R., Olmer, R., et al. (2011). A practical synthesis of Rho-Kinase inhibitor Y-27632 and fluoro derivatives and their evaluation in human pluripotent stem cells. Org. Biomol. Chem. 9, 5503-5510
47. Pannell, D., and Ellis, J. (2001). Silencing of gene expression: Implications for design of retrovirus vectors. Rev. Med. Virol. 11, 205-217
48. Pfaff, N., Lachmann, N., Ackermann, M., et al. (2013). A ubiquitous chromatin opening element prevents transgene silencing in pluripotent stem cells and their differentiated progeny. Stem Cells 31, 488-499
49. Philippe, S., Sarkis, C., Barkats, M., et al. (2006). Lentiviral vectors with a defective integrase allow efficient and sustained transgene expression in vitro and in vivo. Proc. Natl. Acad. Sci. U.S.A. 103, 17684-17689
50. Pichon, C., Billiet, L., and Midoux, P. (2010). Chemical vectors for gene delivery: Uptake and intracellular trafficking. Curr. Opin. Biotechnol. 21, 640-645
51. Reubinoff, B.E., Pera, M.F., Fong, C.Y., et al. (2000). Embryonic stem cell lines from human blastocysts: Somatic differentiation in vitro. Nat. Biotechnol. 18, 399-404
52. Ritner, C., Wong, S.S., King, F.W., et al. (2011). An engineered cardiac reporter cell line identifies human embryonic stem cell-derived myocardial precursors. PLoS One 6, e16004
53. Schinzel, R.T., Ahfeldt, T., Lau, F.H., et al. (2011). Efficient culturing and genetic manipulation of human pluripotent stem cells. PLoS One 6, e27495
54. Schlegelberger, B., Metzke, S., Harder, S., et al. (1999). Classical and molecular cytogenetics of tumor cells. In Diagnostic Cytogenetics. Wegner, R-D., ed. (Springer Verlag, New York), pp. 151-185
55. Sun, N., Lee, A., and Wu, J.C. (2009). Long term non-invasive imaging of embryonic stem cells using reporter genes. Nat. Protoc. 4, 1192-1201
56. Templin, C., Zweigerdt, R., Schwanke, K., et al. (2012). Transplantation and tracking of human-induced pluripotent stem cells in a pig model of myocardial infarction: Assessment of cell survival, engraftment, and distribution by hybrid single photon emission computed tomography/computed tomography of sodium iodide symporter transgene expression. Circulation 126, 430-439
57. Wade-Martins, R. (2011). Developing extrachromosomal gene expression vector technologies: An overview. Methods Mol. Biol. 738, 1-17
58. Wurm, M., Gross, B., Sgodda, M., et al. (2011). Improved lentiviral gene transfer into human embryonic stem cells grown in co-culture with murine feeder and stroma cells. Biol. Chem. 392, 887-895
59. Xia, X., Zhang, Y., Zieth, C.R., and Zhang, S.C. (2007). Transgenes delivered by lentiviral vector are suppressed in human embryonic stem cells in a promoter-dependent manner. Stem Cells Dev. 16, 167-176
60. Xu, X.Q., Graichen, R., Soo, S.Y., et al. (2008a). Chemically defined medium supporting cardiomyocyte differentiation of human embryonic stem cells. Differentiation 76, 958-970
61. Xu, X.Q., Zweigerdt, R., Soo, S.Y., et al. (2008b). Highly enriched cardiomyocytes from human embryonic stem cells. Cytotherapy 10, 376-389
62. Yang, P.C (2012). Is reliable in vivo detection of stem cell viability possible in a large animal model of myocardial injury? Circulation 126, 388-390
63. Yao, S., Sukonnik, T., Kean, T., et al. (2004). Retrovirus silencing, variegation, extinction, and memory are controlled by a dynamic interplay of multiple epigenetic modifications. Mol. Ther. 10, 27-36
64. Ziello, J.E., Huang, Y., and Jovin, I.S. (2010). Cellular endocytosis and gene delivery. Mol. Med. 16, 222-229
65. Zwaka, T.P., and Thomson, J.A. (2003). Homologous recombination in human embryonic stem cells. Nat. Biotechnol. 21, 319-321
66. Zweigerdt, R., Olmer, R., Singh, H., et al. (2011). Scalable expansion of human pluripotent stem cells in suspension culture. Nat. Protoc. 6, 689-700